↧
Buccolam – First Paediatric Use Marketing Authorisation
Buccolam (oromucosal midazolam) is approved for the treatment of prolonged acute convulsive seizures in children aged from 3 months to <18 years. It is the first medicine to be approved under the...
View ArticleBuccolam
Company: Viropharma Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Midazolam (as hydrochloride) 2.5mg, 5mg, 7.5mg, 10mg. Description: Oromucosal solution in pre-filled...
View ArticleAccord Healthcare launch Midazolam
Accord Healthcare is delighted to announce the launch of Midazolam 1mg/ml solution for injection/infusion, the first in their Liberandum® range which comes in a twist box containing 1 x 5ml pre-filled...
View Article